...mixed results (see "Hong Kong's First Wave" ). Paul Bonanos elamipretide ophthalmic solution 1% (MTP-131, bendavia, ocuvia, ss-31) IV elamipretide...

...previously completed the Phase II MMPOWER trial in 36 patients with mitochondrial myopathy. In MMPOWER, IV elamipretide...

...patients ages 60-85 with documented mitochondrial dysfunction showed that a single infusion of 0.25 mg/kg/hour IV elamipretide...
...Heart Failure Society of America meeting in Orlando. Stealth BioTherapeutics Inc. , Newton, Mass. Product: IV elamipretide...

...mitochondrial myopathy associated with genetically confirmed mitochondrial disease showed that the 0.25 mg/kg/hour dose of IV elamipretide...
...to start the MMPOWER-2 extension study of MMPOWER. Stealth BioTherapeutics Inc. , Newton, Mass. Product: IV elamipretide...